IL69514A0 - Recombinant dna molecules,process for their production,their use for production of hepatitis b surface antigen(hbsag)and pharmaceutical compositions containing this hbsag - Google Patents

Recombinant dna molecules,process for their production,their use for production of hepatitis b surface antigen(hbsag)and pharmaceutical compositions containing this hbsag

Info

Publication number
IL69514A0
IL69514A0 IL69514A IL6951483A IL69514A0 IL 69514 A0 IL69514 A0 IL 69514A0 IL 69514 A IL69514 A IL 69514A IL 6951483 A IL6951483 A IL 6951483A IL 69514 A0 IL69514 A0 IL 69514A0
Authority
IL
Israel
Prior art keywords
hbsag
production
hepatitis
pharmaceutical compositions
recombinant dna
Prior art date
Application number
IL69514A
Original Assignee
Max Planck Gesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Max Planck Gesellschaft filed Critical Max Planck Gesellschaft
Publication of IL69514A0 publication Critical patent/IL69514A0/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse transcribing DNA viruses
    • C12N2730/00011—Details
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Virology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Saccharide Compounds (AREA)
  • Peptides Or Proteins (AREA)
IL69514A 1982-09-09 1983-08-17 Recombinant dna molecules,process for their production,their use for production of hepatitis b surface antigen(hbsag)and pharmaceutical compositions containing this hbsag IL69514A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8225685 1982-09-09

Publications (1)

Publication Number Publication Date
IL69514A0 true IL69514A0 (en) 1983-11-30

Family

ID=10532786

Family Applications (1)

Application Number Title Priority Date Filing Date
IL69514A IL69514A0 (en) 1982-09-09 1983-08-17 Recombinant dna molecules,process for their production,their use for production of hepatitis b surface antigen(hbsag)and pharmaceutical compositions containing this hbsag

Country Status (3)

Country Link
EP (1) EP0105141A3 (en)
JP (1) JPS5974991A (en)
IL (1) IL69514A0 (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE73349T1 (en) * 1984-06-18 1992-03-15 Chiron Corp HEPATITIS SURFACE ANTIGEN PARTICLE VACCINATION.
WO1986001534A1 (en) * 1984-09-04 1986-03-13 Takeda Chemical Industries, Ltd. Recombinant dna and its use
WO1986003411A1 (en) * 1984-12-12 1986-06-19 Takeda Chemical Industries, Ltd. Process for preparing novel protein
WO1986007384A1 (en) * 1985-06-03 1986-12-18 Takeda Chemical Industries, Ltd. Process for preparing hapatitis b virus surface antigen p31
FR2571737B1 (en) * 1984-10-15 1987-02-20 Agronomique Inst Nat Rech CLONING OR EXPRESSION VECTORS COMPRISING THE GENOME OF AVIAN ERYTHROBLASTOSIS VIRUS AND CELLS TRANSFECTED BY SUCH VECTORS
EP0264166B1 (en) 1986-04-09 1996-08-21 Genzyme Corporation Transgenic animals secreting desired proteins into milk
EP0288198A3 (en) * 1987-04-20 1989-03-29 Takeda Chemical Industries, Ltd. Production of peptide
US5304637A (en) * 1987-07-13 1994-04-19 Gist-Brocades N.V. Expression and purification of human interleukin-3 and muteins thereof
CA1309044C (en) * 1987-11-09 1992-10-20 Toshiya Takano Method of producing foreign gene products
US6384194B1 (en) 1987-12-16 2002-05-07 Dsm N.V. Expression and purification of human interleukin-3 and muteins thereof
KR100312534B1 (en) * 1993-04-28 2002-05-13 성재갑 Immunoblot kit for simultaneous detecting antibodies to hepatitis c virus and hepatitis b virus and immunoblot analysis

Also Published As

Publication number Publication date
JPS5974991A (en) 1984-04-27
EP0105141A2 (en) 1984-04-11
EP0105141A3 (en) 1985-12-04

Similar Documents

Publication Publication Date Title
YU140380A (en) Process for obtaining dna fragment of hepatitis b virus
PT72322B (en) Process for preparation of recombinant dna molecules and of polipeptides similar to human interferon
PT77173B (en) Process for preparing novel phenethanolamines and of pharmaceutical compositions containing the same
PT77897B (en) Process for the production of cell lines used for the preparation of proteins and pharmaceutical compositions containing such proteins
PH20744A (en) Novel dna,method of producing them and pharmaceutical composition containing the same
PT80118A (en) Process for the manufacture of novel ceramic materials and materials thus obtained
PT76451B (en) Process for preparing small peptides with the specificity of foot and mouth disease viral antigens and of veterinary compositions containing the same
IL69514A0 (en) Recombinant dna molecules,process for their production,their use for production of hepatitis b surface antigen(hbsag)and pharmaceutical compositions containing this hbsag
GB2042554B (en) Method for preparation of recombinant dna
PT73021A (en) Process for producing dna sequences of recombinant dna molecules and polipeptides with specificyty on foot mouth disease as viral antigens
ZA833446B (en) Process for the preparation of cell-and tissue-regenerating substances
ZA861767B (en) Process for preparing hepatitis b surface antigen containing particles in novel forms which are highly immunogenic
PT76657B (en) Process for preparing 4-aryl-4-piperidinecarbinols and of pharmaceutical compositions containing the same
PT80794A (en) Process for the preparation of novel isoindolinyl-alkyl-piperazines and of pharmaceutical compositions containing the same
PT77217A (en) Process for preparing 3-phenoxy-1-azetidine-carboxamides and of pharmaceutical compositions containing the same
DE2961867D1 (en) Indolylalkyl amines, pharmaceutical preparations containing them and process for their manufacture
DE3071972D1 (en) Process for concentration of tumor-inhibiting substances
GB8807790D0 (en) Tetracosahedral siliceos particles & process for preparation thereof
PT75042A (en) Process for the preparation of apovincaminates and pharmaceutical compositions containing them
GB2073747B (en) Triazolopyridinone compounds process for the preparation thereof and pharmaceutical preparations containing them
GB2064322B (en) Process for purifying particles of biological origin particularly the surface antigen of the virus of hepatitis b (aghbs)
PT71806A (en) Process for preparing pharmaceutical composition comprising modified polyriboinosinic-polyribocytidylic acid for induction of interferon in primates
DE3173775D1 (en) Mutant of hemorrhagic septicemia virus, vaccine containing it and process for its preparation
PT76426A (en) Process for preparing novel 2-beta-d-ribofuranosylselenazole-4-carboxamide compounds and of pharmaceutical compositions containing the same
PT74994A (en) Improved process for the preparation of new 4-amino benzylamines and of pharmaceutical compositions containing them